Asymmetric total synthesis and stereochemical revision of gymnangiamide

Organic Letters

Volumn 11, Issue 9, 2009, Pages 1995-1997

  Tone, Hitoshi ^a   Buchotte, Marie ^a   Mordant, Celine ^a   Guittet, Eric ^b   Ayad, Tahar ^a   Ratovelomanana Vidal, Virginie ^a  

^a PSL RESEARCH UNIVERSITY   (France)

^b INSTITUT DE CHIMIE DES SUBSTANCES NATURELLES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GYMNANGIAMID; OLIGOPEPTIDE;

ANIMAL; ARTICLE; BIOLOGY; CHEMICAL STRUCTURE; CHEMISTRY; COELENTERATE; NUCLEAR MAGNETIC RESONANCE; STEREOISOMERISM; SYNTHESIS;

ANIMALS; HYDRA; MARINE BIOLOGY; MOLECULAR STRUCTURE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; OLIGOPEPTIDES; STEREOISOMERISM;

EID: 65549116499     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol900184d     Document Type: Article

References (25)

1. Milanowski, D. J.; Gustafson, K. R.; Rashid, M. A.; Pannell, L. K.; McMahon, J. B.; Boyd, M. R. J. Org. Chem. 2004, 69, 3036.
2. For reviews, see: (a) Noyori, R.; Tokunaga, M.; Kitamura, M. Bull. Chem. Soc. Jpn. 1995, 68, 36.
3. (b) Ratovelomanana-Vidal, V.; Genet, J.-P. Can. J. Chem. 2000, 78, 846.
4. (c) Pellissier, H. Tetrahedron 2008, 64, 1563.
5. (d) Hamada, Y.; Makino, K. J. Synth. Org. Chem. 2008, 66, 1057.
6. For some applications in organic synthesis, see: (e) Scalone, M.; Waldmeier, P. Org. Process Res. Dev. 2003, 7, 418.
7. (f) Eustache, F.; Dalko, P. I.; Cossy, J. J. Org. Chem. 2003, 68, 9994.
8. (g) Mordant, C.; Dünkelman, P.; Ratovelomanana-Vidal, V.; Genet, J.-P. Chem. Commun 2004, 1296.
9. (h) Labeeuw, O.; Phansavath, P.; Genet, J.-P. Tetrahedron: Asymmetry 2004, 15, 1899.
10. (i) Makino, K.; Goto, T.; Hiroki, Y.; Hamada, Y. Angew. Chem., Int. Ed 2004, 43, 882.
11. (j) Ito, M.; Kitahara, S.; Ikariya, T. J. Am. Chem. Soc. 2005, 127, 6172.
12. (k) Mordant, C.; Reymond, S.; Tone, H.; Lavergne, D.; Touati, R.; Ben Hassine, B.; Ratovelomanana-Vidal, V.; Genet, J.-P. Tetrahedron 2007, 63, 6115.
13. (a) Jeulin, S.; Champion, N.; Dellis, P.; Ratovelomanana-Vidal, V.; Genet, J.-P. Synthesis 2005, 3666.
14. (b) Duprat de Paule, S.; Jeulin, S.; Ratovelomanana-Vidal, V.; Genet, J.-P.; Champion, N.; Dellis, P. Eur. J. Org. Chem. 2003, 1931.
15. (c) Jeulin, S.; Duprat de Paule, S.; Ratovelomanana-Vidal, V.; Genet, J.-P.; Champion, N.; Dellis, P. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 5799.
16. (a) Mordant, C.; Ratovelomanana-Vidal, V.; Genet, J.-P. Org. Lett. 2001,12, 1909.
17. (b) Mordant, C.; Reymond, S.; Ratovelomanana-Vidal, V.; Genet, J.-P. Tetrahedron 2004, 60, 9715.
18. Brooks, D.; Lu, L. D. L.; Masamune, S. Angew. Chem., Int. Ed. Engl. 1979, 18,72.
19. (a) Finch, N.; Fitt, J. J.; Hsu, I. H. S. J. Org. Chem. 1975, 40, 206.
20. (b) Greene, A. E.; Le Drian, C.; Crabbe, P. J. Am. Chem. Soc. 1980, 102, 7583.
21. (a) Feichtinger, K.; Zapf, C.; Sings, H. L.; Goodman, M. J. Org. Chem. 1998, 63, 3804.
22. (b) Feichtinger, K.; Sings, H. L.; Baker, T. J.; Matthews, K.; Goodman, M. J. Org. Chem. 1998, 63, 8432.
23. 27D -32.5 (c 0.24, MeOH) of the natural product. See Supporting Informationfor NMR data.
24. 2O with 0.1% TFA as eluent. Generally, peptides tend to retain variable amounts of water and acids (as counterions or residual acid) resulting from the final stage of purification or isolation. Sewald, N., Jakubbe, H.-D., Eds. Peptides: Chemistry and Biology; Wiley-VCH: Weinheim, Germany, 2002; Chapter 2, pp 5-59.
25. 27D -32.5 (c 0.24, MeOH) of the natural product.